Celecoxib pathways:  pharmacokinetics and pharmacodynamics.
Anti-Inflammatory Agents, Non-Steroidal
Aryl Hydrocarbon Hydroxylases
Biomarkers, Pharmacological
Cardiovascular Abnormalities
Celecoxib
Cyclooxygenase 1
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cytochrome P-450 CYP2C9
Genetic Association Studies
Humans
Inflammation
Metabolic Networks and Pathways
Pyrazoles
Sulfonamides
Treatment Outcome
